Skip to main content

Table 2 Eligibility criteria for patient participation in the Rhode Island collaborative practice agreement for naloxone (CPAN)

From: Orienting patients to greater opioid safety: models of community pharmacy-based naloxone

▪ Voluntarily request
▪ Recipient of emergency medical care for acute opioid poisoning
▪ Suspected illicit or nonmedical opioid user
▪ High dose opioid prescription (>100 morphine mg equivalents daily)
▪ Methadone prescription to opioid naïve patient
▪ Dispensed an opioid prescription and:
 ▪ History of smoking
 ▪ COPD
 ▪ Respiratory illness or obstruction
 ▪ Renal dysfunction or hepatic disease
 ▪ Known or suspected concurrent alcohol abuse
 ▪ Concurrent benzodiazepine prescription
 ▪ Concurrent SSRI or TCA anti-depressant prescription
▪ Recently released prisoners from a correctional facility
▪ Released from opioid detoxification or mandatory abstinence program
▪ Patients entering a methadone maintenance treatment program
▪ Patients that may have difficulty accessing emergency medical services
  1. SOURCE: Rhode Island Board of Pharmacy, 2011